PharmaTalkRadio

About The Episode As patient-centricity influences every part of the clinical trial process, sponsors may be surprised at how they impact eCOA strategy.  On this episode, THREAD Research's Chris Watson and Rebecca Tomalty share their expertise and experience, strategizing and developing patient-centric eCOAs to avoid surprise costs and delays. Listeners will learn: when to start thinking about eCO...

About This Episode:  DataArt's engineering capabilities with xCures' oncology expertise created a Natural Language Processing tool. This collaboration tackles the difficult task of ingesting a patient's health records, parsing free-text cancer notes, in order to help patients navigate their options for oncology treatments.    This Conversation Specifically Addresses: The unique challenges facing x...

About This Episode:  What is in the future for biosimilars?  In this episode, Pierre Bourdage, Chief Operating Officer at Sandoz, lays out the promise and potential of biosimilars, and the important role they play in healthcare system sustainability. We also hear about the new initiative Act4Biosimilars which addresses the challenges of biosimilar approvability, accessibility, acceptability and af...

DPHARM Directors, Valerie Bowling and Tracey Kimball, provide a brief overview of what to expect at the 12th annual DPHARM: Disruptive Innovations to Modernize Clinical Research conference. Get 10% off with code TEML.

In this 9 minute webinar, CRAACO® Conference Producer, Andrew Goldstein is joined by Executive Director, Valerie Bowling where they give a summary on what you can expect at the CRAACO: Clinical Research as a Care Option conference. Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system, better health outcomes, lower cost o...

Directors Valerie Bowling and Kate Woda provide a quick overview on what to expect at the 9th annual Mobile Tech in Clinical Trials in under 9 minutes. Get 10% off with code TEML.

In this podcast, Valerie Bowling, Director of the PODD: Partnership Opportunities in Drug Delivery conference gives a 5 minute overview on what you can expect at the 12th annual PODD taking place October 24-25 at the Westin Copley Place in Boston. Learn more about the upcoming conference at poddconference.com

Summary: Join us for an important discussion about the necessity to adjust and adopt media and research strategies to ensure clinical trial recruitment of diverse populations. PharmaTalkRadio’s Valerie Bowling speaks with BBK Worldwide industry experts Justin Jones and Gaby Grekin who will share specific strategies and approaches to apply at the research and media planning stage to achieve more ba...

About the Episode: The number of biotech companies out there makes the struggle to find good talent and good outsourcing partners more difficult and more expensive. As a biotech CMO, working with a CRO more worried about delivering their margins than delivering on what you need leads to an insourcing problem of being inappropriately staffed and an outsourcing problem of not being serviced. In this...

About This Episode:  Dr Derk Arts, Founder and CEO of Castor, lays out what he views as the next phase of data presentation to regulatory agencies, moving away from the standard SDTM (study data tabulation model) into something that more accurately represents the diverse streams of data that are being generated. Potential impacts include: drug approvals based on quality of life, a step forward int...

COVID-19 changed the clinical research landscape by proving the use and efficacy of DCTs, patient-centricity and adaptive designs. Dr Ubavka DeNoble, Executive Vice President of Biotech Operations and Senior Medical Officer of Parexel Biotech shares advice on how CMOs can think about leadership, change management and investing in new technologies such as artificial intelligence, improved data coll...

About This Episode:  What is the future of drug delivery for patients, and how do we get there?  In this episode, Dr Shawn Davis, who leads the Drug Delivery team of the Biopharmaceuticals Development organization at AstraZeneca, lays out a bold vision discussing how the future of drug delivery is patients interacting less with their disease, and what steps we can take to make that future a realit...

About the Episode:  Creating options for patients with decentralized clinical trials can provide tremendous benefits for certain patients and indications. In this podcast, Labcorp’s Linda Ross, Associate Director of Commercial Strategy, Decentralized Clinical Trials, brings an on-the-ground perspective to the benefit of incorporating decentralized strategies into your clinical trial approach. Havi...

About This Episode:  Current efforts to source and disseminate patient insights in clinical trial planning are expensive and time-consuming.  In this episode, Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD Research, discusses how patient voice listening technology is enhancing and disrupting clinical research by making it easier to collect and use patient respon...

Dr Viney joined the CMO Summit 360° in October 2021 to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies.  Learn more about the 10th annual CMO Summit 360° taking place April 4-5, 2022 here.

In this podcast, hear a keynote session from the 2021 Chief Medical Officer Summit 360˚ with Dr Ron Cohen on his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their CEOs and add value to their companies. Learn more about the 10th annual Chief Medical Officer Summit taking place...

Conference Producer, Andrew Goldstein, walks through what you can expect to learn and who you'll hear from at the upcoming Chief Medical Officer Summit 360º taking place April 4-5, 2022 in Boston, MA, including: Clinical development and operationsRelationships within the C-suite and team buildingThe role of the CMO in biotech financingExternal communicationsProfessional development For more inform...

About the Episode:  In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing t...

About the Episode:  Daniel Chen, MD, PhD, Immuno-Oncology 360º 2022 Strategic Advisor, Physician Scientist, Cancer Immunotherapy and Board of Directors, Society for Immunotherapy of Cancer (SITC) and co-author of the Cancer Immunity Cycle, discusses five talks he is excited for, and why, at the upcoming Immuno-Oncology360 conference. The 2022 summit will be held March 16th through the 18th, 2022 a...

This 7 minute podcast summarizes what you can expect at the 8th annual Immuno-Oncology 360° conference. IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. Keynotes include: Dr Gregg Semenza, Johns Hopkins University School of MedicineDr Rachel Haurwitz, Caribou BiosciencesDr Christine B...

Conference Producer, Mark Scherzer, talks through what to expect at the upcoming Patients as Partners EU virtual conference taking place 24-25 January 2022.  The 6th annual conference will bring together pharma, biotech, CROs and technologists to figure out how to advance patient involvement in medicines development. Experts from Novartis, Pfizer, Merck, EMD Serono, Janssen, Johnson & Johnson,...

About the Episode: How can artificial intelligence maintain the pace of clinical trials from the COVID-19 pandemic to bring therapeutics to patients faster? Suresh Katta, CEO and founder of Saama Technologies, sits down to discuss exactly how artificial intelligence can be utilized to design better trials from the start, reduce costs and benefit patients and pharma in the long run.    Key Takeaway...

About the Episode: How can therapeutics like biologics and small molecule drugs evolve in their delivery? Finn Doyle, SVP and General Manager of ENHANZE® at Halozyme, sits down to discuss exactly how these innovative therapeutics can be delivered subcutaneously where they have previously only been administered via IV, the impacts of doing so, and the keys to successful drug delivery collaborations...

About the Episode: What does the future of eyecare look like? How does a global company stay innovative? Listen to this podcast to hear Dr Xiao-Yu Song, Johnson & Johnson Vision, providing the latest information on J&J Vision's new products, and her approach to innovation.    Key Takeaways:  How to encourage innovation in a large, global company What the current and future eyecare needs ar...

About the Episode: As the COVID-19 pandemic encourages the widespread adoption of decentralized clinical trial models, there are opportunities to optimize existing processes to make clinical research easier for sites and sponsors to conduct, and for patients to participate. Jonathan Andrus, Clinical Ink, discusses his advice as a flexible data collection expert, thoughts on wider adoption of DCTs...